Try GOLD - Free
Novo moves HC to restrain Sun Pharma
Mint Mumbai
|December 10, 2025
As blockbuster weight loss drug semaglutide inches closer to losing its patent exclusivity in India, innovator Novo Nordisk is upping its ante against local firms wanting to launch copies of the drug.
The Danish drugmaker on Tuesday moved the Delhi High Court, seeking to restrain domestic giant Sun Pharmaceutical Industries from launching its generic version of semaglutide, a widely prescribed drug for diabetes and weight loss.
The matter was heard briefly by a bench headed by justice Tejas Karia, who transferred the case to the bench already hearing Novo's parallel litigation against Dr. Reddy’s Laboratories and Natco Pharma concerning the same patent.
The plea is likely to be taken up today before justice Manmeet Pritam Singh Arora, who last week allowed Dr. Reddy's Laboratories to export semaglutide to non-patent nations.
This story is from the December 10, 2025 edition of Mint Mumbai.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Mint Mumbai
Mint Mumbai
Behind Paramount’s relentless campaign to woo Warner Discovery, Donald Trump
Paramount Chief Executive David Ellison knew his latest bid for Warner Bros.
4 mins
December 10, 2025
Mint Mumbai
WHY PORTFOLIO STRATEGY, NOT STOCK PICKING, DECIDES WHO WINS IN THE MARKET
When market context changes and focus shifts to new themes, equity investing must anticipate, prepare and respond.
3 mins
December 10, 2025
Mint Mumbai
What to expect from India's customs reforms
Businesses have flagged the need for a simpler customs duty regime.
2 mins
December 10, 2025
Mint Mumbai
Govt picks fund managers for ₹1 tn deep-tech boost
DST has appointed BIRAC and TDB, and is set to add Sidbi and SBI Funds Management soon
2 mins
December 10, 2025
Mint Mumbai
Indian comics get Gen Z reboot
Indian comic heroes like Chacha Chaudhary, Nagraj, Super Commando Dhruv, Doga, Suppandi and Shikari Shambu are levelling up to face anime legends such as Naruto, Tanjiro, Goku, Saitama, Light Yagami, and Luffy.
2 mins
December 10, 2025
Mint Mumbai
Trump's at it again
Just hours before a US delegation arrived in New Delhi to wrap up a long-pending trade deal, Donald Trump hinted at a fresh tariff to be levied on India.
1 min
December 10, 2025
Mint Mumbai
Margin strain prompts wealth firms to expand
With a surge in affluent people, competition has intensified in the space
2 mins
December 10, 2025
Mint Mumbai
GenAI builders may have to pay creators
India is crafting a policy outline on how architects of artificial intelligence (AI) can use copyrighted material, a development that promises to impact AI giants and startups digesting vast amounts of data to spit out everything from quirky images to medical analyses.
3 mins
December 10, 2025
Mint Mumbai
FIRs against Anil Ambani’s son, group cos
The Central Bureau of Investigation (CBI) on Tuesday carried out searches at the residence of industrialist Anil Ambani's son Jai Anmol Ambani in Mumbai after registering a case against him and a Reliance ADA Group company—Reliance Home Finance Ltd (RHFL) on a complaint of Union Bank of India, which alleged that a fraud of ₹228 crore was committed against the bank.
1 min
December 10, 2025
Mint Mumbai
Sam Altman's sprint to correct OpenAI's direction and fend off Google
The CEO is prioritizing achieving mass popularity through ChatGPT versus moonshot projects like artificial general intelligence
9 mins
December 10, 2025
Listen
Translate
Change font size